1
|
G6PD deficiency: the genotype-phenotype association.
|
Blood Rev
|
2007
|
1.86
|
2
|
High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.
|
J Mol Diagn
|
2009
|
1.06
|
3
|
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
|
J Clin Oncol
|
2006
|
0.97
|
4
|
Frequency of congenital dyserythropoietic anemias in Europe.
|
Eur J Haematol
|
2010
|
0.94
|
5
|
A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients.
|
Stem Cells
|
2005
|
0.93
|
6
|
4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins.
|
Haematologica
|
2009
|
0.92
|
7
|
Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
|
Am J Hematol
|
2009
|
0.91
|
8
|
Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
|
Liver Transpl
|
2009
|
0.90
|
9
|
Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.
|
Ann Hematol
|
2008
|
0.90
|
10
|
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
|
Br J Haematol
|
2013
|
0.86
|
11
|
[Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia].
|
Gac Sanit
|
2011
|
0.85
|
12
|
Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression.
|
Blood
|
2005
|
0.84
|
13
|
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera.
|
Mol Cancer
|
2013
|
0.78
|
14
|
Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).
|
Cancer Cell Int
|
2012
|
0.76
|
15
|
beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C.
|
Adv Hematol
|
2009
|
0.75
|